Epistatic interactions modulate the evolution of mammalian mitochondrial respiratory complex components.
BACKGROUND
The deleterious effect of a mutation can be reverted by a second-site interacting residue. This is an epistatic compensatory process explaining why mutations that are deleterious in some species are tolerated in phylogenetically related lineages, rendering evident that those mutations are, by all means, only deleterious in the species-specific context. Although an extensive and refined theoretical framework on compensatory evolution does exist, the supporting evidence remains limited, especially for protein models. In this current study, we focused on the molecular mechanism underlying the epistatic compensatory process in mammalian mitochondrial OXPHOS proteins using a combination of in-depth structural and sequence analyses.


RESULTS
Modeled human structures were used in this study to predict the structural impairment and recovery of deleterious mutations alone and combined with an interacting compensatory partner, respectively. In two cases, COI and COIII, intramolecular interactions between spatially linked residues restore the folding pattern impaired by the deleterious mutation. In a third case, intermolecular contact between mitochondrial CYB and nuclear CYT1 encoded components of the cytochrome bc1 complex are likely to restore protein binding. Moreover, we observed different modes of compensatory evolution that have resulted in either a quasi-simultaneous occurrence of a mutation and corresponding compensatory partner, or in independent occurrences of mutations in distinct lineages that were always preceded by the compensatory site.


CONCLUSIONS
Epistatic interactions between individual replacements involving deleterious mutations seems to follow a parsimonious model of evolution in which genomes hold pre-compensating states that subsequently tolerate deleterious mutations. This phenomenon is likely to have been constraining the variability at coevolving sites and shaping the interaction between the mitochondrial and the nuclear genome.
Azevedo
Luísa
L
IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal. lazevedo@ipatimup.pt
Carneiro
João
J
van Asch
Barbara
B
Moleirinho
Ana
A
Pereira
Filipe
F
Amorim
António
A
D000818:Animals; D004272:DNA, Mitochondrial / Q000235:genetics*; D014450:Electron Transport Complex III / Q000235:genetics; D003576:Electron Transport Complex IV / Q000235:genetics; D004843:Epistasis, Genetic; D019143:Evolution, Molecular; D006801:Humans; D008322:Mammals / Q000235:genetics*; D008958:Models, Molecular; D009154:Mutation; D010802:Phylogeny; D017434:Protein Structure, Tertiary
D004272:DNA, Mitochondrial; D003576:Electron Transport Complex IV; D014450:Electron Transport Complex III